Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
Eduardo Mysler, Mariana Caubet, Ana Lizarraga Organización Medica de Investigación, Buenos Aires, ArgentinaCorrespondence: Eduardo Mysler Email e.mysler@omiargentina.com.arAbstract: Rheumatoid arthritis (RA) is the most prevalent form of inflammatory arthritis. It is a profound...
Guardado en:
Autores principales: | Mysler E, Caubet M, Lizarraga A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45b1d4dc816145d7b84c99f4c59ddaae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management of rheumatoid arthritis during pregnancy: challenges and solutions
por: Krause ML, et al.
Publicado: (2016) -
Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study
por: AlOmair M, et al.
Publicado: (2021) -
Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
por: Lurati A, et al.
Publicado: (2021) -
Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
por: Ulusoy H, et al.
Publicado: (2020) -
The onset of rheumatoid arthritis following trauma
por: Brawer AE, et al.
Publicado: (2016)